Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sandhya Bohini"'
Autor:
Klaus Klumpp, Sandhya Bohini, Changhua Ji, Stefan Ries, Georg Fertig, Yang Liu, Chandra Pamulapati, Werner Rubas, Michael Brandt, Michael Schraeml, Han Ma
Publikováno v:
Hepatology. 61:1136-1144
CD81 is a required receptor for hepatitis C virus (HCV) infection of human hepatocytes in vitro. We generated several high-affinity anti-human CD81 monoclonal antibodies (mAbs) that demonstrated potent, specific, and cross-genotype inhibition of HCV
Autor:
Rosario Garrido, Chandrasena Pamulapati, Stefan Ries, Vladimir Vexler, Sandhya Bohini, Michael Schraeml, Changhua Ji, Klaus Klumpp, Li Yu, Hans Peter Grimm, Michael Brandt, Usha Singh, Han Ma, Priya Sriraman
Publikováno v:
mAbs. 5:776-786
CD81 is an essential receptor for hepatitis C virus (HCV). K21 is a novel high affinity anti-CD81 antibody with potent broad spectrum anti-HCV activity in vitro. The pharmacokinetics (PK), pharmacodynamics and liver distribution of K21 were character
Autor:
Denise Teoh, Han Ma, Erhard Kopetzki, Zi Zong Ho, Changhua Ji, Sandhya Bohini, Konduru S. R. Sastry, Klaus Klumpp, Jennifer Cano, Stefan Ries, Georg Tiefenthaler, Surya Sankuratri, Antonio Bertoletti, Tenny Tang, Antony Chen, Paul A. MacAry, Patrick T F Kennedy
Publikováno v:
Hepatology. 56:2027-2038
During antiviral therapy, specific delivery of interferon-α (IFNα) to infected cells may increase its antiviral efficacy, trigger a localized immune reaction, and reduce the side effects caused by systemic administration. Two T-cell receptor-like a
Autor:
Changhua Ji, Sandhya Bohini, Ford Kirschenbaum, Harald Kropshofer, Surya Sankuratri, Nick Cammack
Publikováno v:
Antiviral Research. 86:A36